0001104659-22-073897.txt : 20220623 0001104659-22-073897.hdr.sgml : 20220623 20220623160634 ACCESSION NUMBER: 0001104659-22-073897 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220621 FILED AS OF DATE: 20220623 DATE AS OF CHANGE: 20220623 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mills C Randal CENTRAL INDEX KEY: 0001370939 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39577 FILM NUMBER: 221035475 MAIL ADDRESS: STREET 1: 18366 CALLE STELLINA CITY: RANCHO SANTA FE STATE: CA ZIP: 92091 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AZIYO BIOLOGICS, INC. CENTRAL INDEX KEY: 0001708527 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 474790334 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12510 PROSPERITY DRIVE STREET 2: SUITE 370 CITY: SILVER SPRING STATE: MD ZIP: 20904 BUSINESS PHONE: 240-247-1143 MAIL ADDRESS: STREET 1: 12510 PROSPERITY DRIVE STREET 2: SUITE 370 CITY: SILVER SPRING STATE: MD ZIP: 20904 4 1 tm2219201-1_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2022-06-21 0 0001708527 AZIYO BIOLOGICS, INC. AZYO 0001370939 Mills C Randal C/O AZIYO BIOLOGICS, INC. 12510 PROSPERITY DRIVE, SUITE 370 SILVER SPRING MD 20904 1 1 0 0 Interim President and CEO Stock Option (Right to Buy) 6.39 2022-06-21 4 A 0 273767 0 A 2032-06-20 Class A Common Stock 273767 273767 D Stock Option (Right to Buy) 6.39 2022-06-21 4 A 0 182511 0 A 2032-06-20 Class A Common Stock 182511 182511 D The option vests and becomes exercisable as to one-third of the underlying shares upon the day following the expiration of the Interim Period (as defined in the Reporting Person's Employment Agreement dated June 21, 2022). The remaining two-thirds of the underlying shares vest and become exercisable, with respect to 25% of such shares, on June 21, 2023, and, with respect to 75% of such shares, in twelve equal quarterly installments thereafter, beginning on September 21, 2023, subject to the Reporting Person's continuous employment with the Issuer through the applicable vesting date. The option vests and becomes exercisable in four equal installments upon the Issuer's achievement of a share price equal to or greater than $12.50, $17.00, $25.00 and $37.00, in each case determined based on twenty consecutive days of trading at or above the applicable threshold, subject to the Reporting Person's continuous employment with the Issuer through the applicable vesting date. /s/ Jeffrey Hamet, Attorney-in-Fact for C Randal Mills 2022-06-23